The Evolution of Sleep Diagnostics and What It Means for Dentists Practicing Dental Sleep Medicine

Dental sleep medicine does not sit outside of medicine. It operates inside a specialty that was deliberately constructed around diagnostic rigor, standardized interpretation, and long-term disease management. Oral appliance therapy is not an alternative system. It is one therapeutic tool within a medical framework designed to identify risk, guide treatment selection, and verify outcomes over time.

For dentists with a growing interest in dental sleep medicine, the history of sleep diagnostics explains many of the realities they encounter today. It clarifies why physicians emphasize testing pathways, why outcomes must be documented objectively, and why symptom improvement alone is no longer considered a sufficient measure of success. It also highlights where dentistry has an opportunity to lead, particularly as workforce shortages and fragmented care increasingly leave patients without adequate follow-up.

As Robyn Woidtke, RN, RPSGT, CCSH, FAAST, frames it, she is not “”a diagnostics expert”” so much as a sleep health professional who has watched the field evolve over decades. As one of the first 500 RPSGTs, she has a firsthand perspective on what has changed in the diagnostic options for sleep and breathing

 From her viewpoint, the most consequential gap in modern sleep care is not necessarily the initial diagnosis or treatment selection. It is the follow-through that can be complex and time-consuming. Much post-diagnosis focus is on “treatment compliance,” which can be difficult for many individuals. . Too often, patients are diagnosed, placed on a device, and then expected to navigate a chronic condition with minimal structured reassessment. Robyn is careful not to label this as a failure of sleep medicine itself. Instead, she points to the practical forces that drive the gap: reimbursement constraints, limited access to trained specialists, and a healthcare system that is more fragmented than cohesive. For dental sleep medicine, that reality clarifies both the opportunity and the responsibility: to build reliable continuity of care by integrating objective verification, repeatable follow-up protocols, and close collaboration with physician partners.

Dentistry has traditionally been procedural and mechanically oriented. Dentists are trained to identify structural problems, intervene directly, and assess results through physical change and patient feedback. Sleep medicine evolved along a different path. From its earliest days, it was built as a diagnostic specialty grounded in physiology, measurement, and interpretation.

This difference explains much of the friction dentists experience when entering sleep medicine. Physicians are trained to ask whether disease is present, how severe it is, what risks it carries, and whether the prescribed treatment has measurably altered the underlying physiology. These questions are not academic. They determine who needs treatment, which therapeutic approach is the most appropriate, and how closely patients must be monitored over time.

Robyn Woidtke, RN, RPSGT, CCSH, FAAST, often uses a comparison that lands quickly with clinicians because it highlights a systems issue, not a device issue. When a patient is diagnosed with cancer, they are typically placed into a defined surveillance pathway with scheduled imaging, clear escalation triggers, and a team that owns follow-up.

She also points to diabetes as another practical example: many health systems connect patients to structured education programs and a Certified Diabetes Care and Education Specialist (CDCES) to guide long-term self-management.

Obstructive sleep apnea, despite being a chronic condition with meaningful cardiovascular, metabolic, and neurocognitive consequences, is frequently handled as a one-and-done event. A diagnosis is made, a device is delivered, and the patient is left to navigate the next steps with limited formal guidance, unsure whether to call the DME provider, the sleep physician, or primary care.

In Robyn’ ‘s view, this gap is driven less by a “”failure of the field”” than by reimbursement constraints, limited access to sleep specialists, and a healthcare system that remains more fragmented than cohesive.

For dentists practicing within the medical model, dentistry’ ‘s recall-based structure can help close this continuity gap when paired with objective verification and tight collaboration with physician partners, so treatment success is monitored over time rather than a singular act at the delivery of the appliance.

For dentists, understanding this diagnostic history helps reframe their role. Appliance delivery is not the endpoint. It is one step in an ongoing medical process.

Sleep was not always measurable. For much of medical history, sleep was understood primarily through subjective observation, patient reports, and behavioral description. Complaints such as excessive sleepiness, insomnia, or unusual nighttime behaviors were noted, but there was no reliable way to observe what was happening physiologically during sleep itself. As a result, sleep disorders were poorly defined, inconsistently diagnosed, and often dismissed as secondary symptoms rather than primary medical conditions.

The modern era of sleep medicine began in the early 1950s, when researchers first demonstrated that sleep could be objectively measured. In 1953, Eugene Aserinsky and Nathaniel Kleitman at the University of Chicago published their landmark discovery of rapid eye movement (REM) sleep, using electroencephalography (EEG) and electrooculography (EOG). This finding established that sleep was not a uniform state, but a dynamic, structured biological process with distinct stages. Shortly thereafter, electromyography (EMG) was incorporated to assess muscle tone, completing the foundational triad of signals still used today.

Throughout the 1950s and 1960s, early research centers at institutions such as Stanford University, the University of Chicago, and UCLA became informal centers of excellence, advancing sleep stage classification and refining measurement techniques. In 1968, the publication of Rechtschaffen and Kales, A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects provided the first widely accepted scoring rules for EEG-based sleep architecture. This was a critical turning point. Sleep could now be measured, classified, and compared across laboratories.

This shift from observation to measurement fundamentally transformed sleep into a diagnosable biological process. Disorders were no longer defined solely by symptoms or patient perception. They could be classified based on reproducible physiologic patterns. Over time, it became clear that consistency mattered as much as innovation. Measurements had to be collected in standardized ways, scored using shared definitions, and interpreted by trained professionals to maintain reliability.

As Robyn Woidtke has emphasized, the goal of sleep diagnostics was never simply data collection. The purpose was clinical decision-making. Sleep medicine was built to produce information that could be compared across patients, clinicians, and centers, allowing treatment decisions to be taught, replicated, and defended. That emphasis on standardization is what allowed sleep medicine to scale beyond academic research units into a recognized clinical specialty.

For dentists, this history explains why screening tools, airway assessments, and anatomic observations, while valuable for identifying risk, cannot replace the gold standard for diagnostic testing. Sleep medicine was intentionally designed to reduce variability and uncertainty, not amplify them. Objective measurement and standardized interpretation remain the foundation on which all modern sleep therapies, including oral appliance therapy, are evaluated.

How Obstructive Sleep Apnea Became a Measurable Disease

Once sleep staging was standardized in the late 1960s, the field reached an inflection point. Clinicians could reliably determine when a patient was asleep and which stage of sleep they were in. The next question was more consequential: what was disrupting sleep and why. This shift marked the transition from descriptive sleep science to applied clinical diagnostics.

In the late 1960s and early 1970s, investigators began to notice that certain patients exhibited repeated arousals, oxygen desaturation[rw1] , and fragmented sleep architecture despite appearing to sleep for adequate durations. Early research at Stanford University, led by William Dement and later Christian Guilleminault, identified a recurring pattern of airflow cessation during sleep accompanied by respiratory effort and oxygen decline. These observations distinguished a new pathophysiologic entity OSA from primary insomnia or hypersomnia[rw2] .

By 1972–1974, clinical papers described what would later be termed obstructive sleep apnea, linking episodic upper airway collapse to excessive daytime sleepiness, cardiovascular strain, and neurocognitive impairment. Importantly, this disorder could not be identified by symptoms alone. Many patients underreported sleepiness, while others acclimated to chronic fatigue. The disease revealed itself only when respiration, airflow, and oxygenation were measured alongside sleep stage.

This realization drove a major expansion in sleep diagnostics. Polysomnography evolved beyond EEG, EOG, and EMG to include nasal airflow sensors, thoracoabdominal effort belts, electrocardiography, and pulse oximetry. By the mid-1970s, the modern polysomnogram had emerged as a multichannel physiologic study, capable of correlating sleep stage, respiratory mechanics, oxygen saturation, and arousal patterns in real time.

Centers such as Stanford, the University of Pennsylvania, and Montefiore Hospital in New York became early clinical reference sites, refining respiratory event definitions and training the first generation of sleep specialists. These efforts culminated in the late 1970s with formal accreditation standards and the first diagnostic classifications of sleep disorders. Obstructive sleep apnea was now a defined medical condition, diagnosed not by complaint but by reproducible physiologic criteria.

Robyn ‘Woidtke’s perspective is particularly relevant here. In the field of sleep medicine, she emphasizes that the use of the polysomnogram provided a “head to toe” picture of the patient all at once, rather than tests conducted on other days or times. The polysomnogram allowed a more complete interpretation of what the patient was experiencing. The one or two nights in the sleep laboratory, although not perfect, were relatively comprehensive and allowed flexibility to add channels and parameters of interest, such as esophageal monitoring for reflux in infants, and to extend the EEG montage for seizure activity. The purpose of defining apneas, hypopneas, and arousals was to create decision-grade data that could guide treatment, be compared across centers, and withstand scrutiny from payers and regulators. Standardization was not an academic exercise. It was a safety mechanism necessary to create the diagnostic infrastructure to ensure adequate treatment and reimbursement.

As respiratory diagnostics matured, metrics such as the apnea–hypopnea index (AHI) emerged as convenient summary measures. Over time, AHI became dominant because it was simple, quantifiable, and easily categorized. However, even early investigators recognized its limitations. Two patients with identical AHI values could have vastly different oxygen burdens, arousal profiles, and clinical risk. This distinction is not new. It was present from the beginning.

For dentists practicing dental sleep medicine today, this historical progression matters. Oral appliance therapy exists because sleep medicine learned to measure airway collapse objectively and correlate it with downstream health effects. Screening tools and craniofacial assessments help identify risk, but they do not replace the diagnostic framework that legitimized the field.

Sleep staging was the first step that allowed clinicians to move beyond “”how long did you sleep”” and begin answering a more meaningful question: what was the quality of that sleep. By distinguishing stages and identifying arousals and fragmentation, staging connected sleep quantity and sleep quality to downstream health, including daytime function, cardiometabolic risk, and neurocognitive performance.

Concerning OSA, respiratory diagnostics aided in clarifying  what was breaking sleep and driving physiologic strain, showing how obstructive events, oxygen desaturation, and repetitive arousals can degrade sleep architecture even when total sleep time appears adequate.

Obstructive sleep apnea became a treatable disease only because measurement replaced assumption. That same principle underpins modern collaboration between dentists and physicians. Objective verification is not a barrier to care. It is the mechanism that allows different disciplines to work from the same clinical truth.

The recognition of obstructive sleep apnea reshaped sleep diagnostics entirely. As clinicians began to understand the systemic risks associated with untreated airway collapse during sleep, testing expanded to include respiratory effort, airflow, oxygen saturation, heart rate variability, and arousals alongside traditional neurophysiologic signals.

Polysomnography unified these measurements into a single diagnostic framework. Its importance was not that it was perfect, but that it provided a comprehensive, standardized view of sleep-related physiology. It created a shared language for severity, risk, and treatment response.

Professional organizations such as the American Academy of Sleep Medicine continues to provide the field with clinical practice guidelines, regularly update the established scoring manual, and establish accreditation standards and training pathways to ensure practice consistency. These safeguards allowed clinicians to trust results across settings and made reimbursement and comparative research possible.

From a dental perspective, this history explains why oral appliance therapy is judged against physiologic benchmarks rather than comfort or adherence alone. Sleep medicine evaluates treatments based on whether they meaningfully change disease burden, not simply whether patients tolerate them.

Sleep diagnostics depend on more than equipment. It depends on systems designed to minimize error and variability. Two clinicians can interpret the same study differently depending on training and experience. Robyn Woidtke has repeatedly emphasized that inter-rater variability is real, and that credentialing, training and education exist to reduce, not eliminate, this variability.

These safeguards were developed because early leaders recognized that poor data quality leads to poor clinical decisions. Inaccurate diagnosis can result in inappropriate treatment selection, false reassurance, or unnecessary escalation of care. The consequences extend beyond individual patients to public safety and the health system cost.

From a dental perspective, this matters because diagnostic errors often appear downstream as treatment failure. An oral appliance may be blamed when the real issue is misclassification of disease severity, missed comorbid disorders, or inadequate baseline testing. Dentists who rely on high-quality diagnostic partners reduce these risks significantly.

Understanding the role of accreditation and credentialing also helps dentists evaluate potential collaborators. Centers that adhere to recognized standards are more likely to provide reliable diagnoses and appropriate follow-up recommendations. This reliability protects both patient outcomes and professional reputation.

The apnea-hypopnea index became the dominant outcome metric because it was simple, familiar, and easily categorized. It allowed insurers and clinicians to define mild, moderate, and severe disease quickly. However, its limitations have become increasingly apparent.

Robyn Woidtke has long cautioned against treating AHI as the sole indicator of therapeutic success. Event counts are influenced by scoring rules and do not always reflect physiologic stress or patient function. Some patients with severe disease report few symptoms, while others with lower AHI experience significant impairment.

Pulse oximetry has become a practical proxy for oxygenation in sleep testing and follow-up, but dentists should understand where SpO2 data can mislead. Even in well-run programs, oximetry is vulnerable to artifact and signal instability.

Low peripheral perfusion, cold extremities, vasoconstriction, movement during sleep, loose sensors, poor probe fit, acrylic nails or nail polish, ambient light intrusion, and device-to-device variability can all create false desaturations or mask true ones. In home environments, those risks compound because setup quality is inconsistent, and troubleshooting is limited.

It is also important to acknowledge an equity issue that has become increasingly well documented. Multiple studies have shown that pulse oximeters can overestimate arterial oxygen saturation in patients with darker skin pigmentation, increasing the risk of “”occult hypoxemia”” and potentially widening disparities when clinicians rely on SpO2 thresholds without context.

This does not mean oximetry is unusable. It means the clinician should treat oxygen metrics as decision-support data, not as a standalone verdict, particularly when the clinical picture and the numbers do not agree.

In the medical model, the practical takeaway is straightforward: interpret SpO2 alongside symptoms, comorbid risk, respiratory indices (when available), sleep architecture ,and arousal burden, and the overall quality of the recorded signal.

When readings are inconsistent, implausible, or discordant with patient function, the next step is not ignore it, or trust it blindly, but to escalate appropriately: repeat the study with improved signal quality, move to a more comprehensive test modality when indicated, and coordinate interpretation with a trained sleep physician. Done correctly, oximetry remains valuable, but only when dentists treat it as one piece of a broader physiologic story rather than the entire story.

For dentists, this reinforces the importance of objective verification that looks beyond a single number.

One of Robyn ‘Woidtke’s most consistent observations is that follow-up is where sleep care most often fails. Workforce shortages, time constraints, and fragmented systems leave many patients without meaningful reassessment. Any validated follow-up, she notes, is better than none, provided the data are actionable and understood.

Dentistry may be uniquely positioned to address this gap. Recall intervals are already embedded in dental practice. Patients return regularly. The opportunity is to use that structure not just to check appliances, but to verify ongoing therapeutic effectiveness.

Longitudinal reassessment acknowledges a basic truth of sleep medicine. A sleep study is a snapshot in time. Weight changes, medications, aging, and health status all influence disease expression. Chronic conditions require periodic reevaluation.

Home sleep apnea testing (HSAT) expanded access to diagnosis by removing one of the biggest bottlenecks in sleep medicine: limited laboratory capacity, long wait times, and the logistical burden of an overnight in-lab study. HSAT improved efficiency because it can be deployed quickly, completed in the ‘patient’s normal sleep environment, and used to identify obstructive sleep apnea in patients who present with a high pretest probability and do not have complicating cardiopulmonary or neurologic conditions. In that defined use case, HSAT can be clinically useful, cost-effective, and scalable.

However, HSAT was never designed to replace clinical judgment. It is a diagnostic tool with constraints, and those constraints matter. HSAT generally captures fewer physiologic channels than in-lab polysomnography, and it cannot characterize sleep stages in the same way. That means key clinical questions still require physician oversight: Is the patient an appropriate HSAT candidate? Was the study technically adequate? Do the findings match the ‘patient’s symptoms and risk profile? Is there reason to suspect central sleep apnea, hypoventilation, severe oxygen instability, insomnia, parasomnias, or another disorder that HSAT will not reliably detect?

Appropriate patient selection, interpretation by trained physicians, and follow-up for inconclusive or negative studies remain essential safeguards. HSAT can simplify logistics, but it does not eliminate complexity. A negative HSAT in a symptomatic, high-risk patient should not automatically be  determined as “”no sleep apnea”.” It should  used as a decision point that may warrant repeat testing, escalation to in-lab evaluation, or a broader differential diagnosis.

Dentists benefit when HSAT is used thoughtfully within a collaborative framework. Strong physician partners help ensure that testing pathways match patient risk, that the diagnostic conclusion is defensible, and that oral appliance therapy is positioned within the medical model as a verified treatment for a verified condition, rather than a response to symptoms alone.

Sleep physicians are trained to work from a broad differential diagnosis rather than a single presumed mechanism. In addition to obstructive sleep apnea, they evaluate central sleep apnea, sleep-related hypoventilation, parasomnias, circadian rhythm disorders, insomnia, and sleep-related movement disorders.

They also integrate key modifiers of sleep and breathing such as medication effects, neurologic disease, cardiopulmonary status, and psychiatric comorbidity into diagnostic and management decisions.

For dental sleep practices, this clinical breadth is not simply academic. It is a practical safeguard against treating symptoms while missing the underlying driver of sleep disruption. Strong physician–dentist collaboration also reduces the therapeutic burden for the patient.

A multidisciplinary approach improves patient-centered communication, clarifies roles and expectations, streamlines follow-up pathways, and increases the likelihood that objective verification and longitudinal care actually occur. In this model, oral appliance therapy is positioned appropriately as one effective treatment option within a coordinated plan, rather than a default intervention applied in isolation.

Sleep medicine now emphasizes ongoing verification of therapeutic effectiveness[rw3] . Objective testing before and after treatment confirms that physiology has changed, not just symptoms. This approach reflects recognition that sleep disorders are chronic and dynamic. In addition, validated sleep-related patient-reported outcome measures (PROMs) are now being used to assess patients’ perceptions beyond objective measures. Dental sleep practices can provide the PROMIS questionnaires, a validated PROM, which can be used easily during recall visits scheduled by the dental sleep provider and can provide updates to medical providers.

For dental sleep medicine, post-titration testing validates success and strengthens professional credibility. It also supports informed adjustments and long-term patient management.

The evolution of sleep diagnostics tells a clear story. Sleep medicine did not advance by intuition, anatomy, or symptom relief alone. It advanced by measurement, standardization, and verification. From the earliest EEG recordings to modern multichannel polysomnography and validated home testing, the field has been shaped by a consistent principle: sleep disorders are medical conditions that require objective diagnosis and ongoing management.

For dentists practicing or entering dental sleep medicine, this history is not academic background. It defines the professional context in which oral appliance therapy exists. Oral appliances work because of a clear mechanism of action: they modify upper airway anatomy and mechanics during sleep, most commonly by stabilizing and advancing the mandible to reduce collapsibility of the airway.

What sleep medicine contributed was not the mechanism itself, but the ability to measure the physiologic outputs of that mechanism in a standardized way, including airflow stability, oxygenation, arousal burden, and downstream cardiopulmonary stress[rw4] .

That is why oral appliances are evaluated not by comfort or adherence alone, but by whether therapy produces measurable physiologic improvement and sustained clinical benefit. Follow-up testing translates the mechanism into decision-grade evidence, confirming that the patient’ ‘s disease expression has meaningfully changed. This expectation is not a barrier imposed on dentistry. It is the foundation that gives dental sleep medicine its credibility within the medical model.

Robyn ‘Woidtke’s perspective brings this into sharp focus. Across decades in sleep she has observed that the most persistent failure in sleep care is not identifying obstructive sleep apnea, but sustaining care after diagnosis. Too often, patients receive a test, a prescription, or a device and then disappear from meaningful follow-up. Sleep apnea, despite its chronic and progressive nature, is still treated in many systems as a one-time event rather than a condition that evolves with age, weight, medications, and comorbid disease.

In summary, this is where dentistry has both an opportunity and a responsibility. Dental practices already operate within a recall-based model. Patients return. Relationships persist. The infrastructure for longitudinal care exists.

What has been missing historically is the consistent integration of objective verification and medical collaboration into that structure. When dentists commit to post-titration testing, periodic reassessment, and shared reporting with physician partners, they are not stepping outside their scope. They are aligning with the very principles on which sleep medicine was built.

The growing reliance on home sleep testing and telehealth makes alignment between dental and medical teams more important, not less. Decentralized care can meaningfully expand patients access to care by reducing travel, wait times, and scheduling barriers, especially in markets with limited sleep specialist availability.

However, decentralizing the pathway can also unintentionally introduce new silos, and those silos carry their own risks: unclear ownership of follow-up, inconsistent patient education, duplicated or missing documentation, and delayed recognition of treatment failure.

When testing, interpretation, titration, and longitudinal reassessment are distributed across multiple touchpoints, patients can be left unsure who owns the next step, and clinicians can lose visibility into whether therapy is truly effective over time.

A coordinated medical-model workflow with explicit handoffs and shared reporting is the safeguard that allows decentralized diagnostics to improve access without compromising continuity.

Practicing within the medical model ultimately protects everyone involved. It protects patients from under- or overtreatment. It protects dentists from being held accountable for diagnostic errors they did not create. It protects physician partners by extending the reach of evidence-based care into a setting where follow-up is more reliable.

Dental sleep medicine does not succeed by distancing itself from medicine. It succeeds by embracing the diagnostic foundations that made the field possible. Dentists who understand where sleep diagnostics came from, why they were designed the way they were, and how outcomes are meant to be verified do more than deliver appliances. They participate meaningfully in the care of a chronic medical condition.

The future of dental sleep medicine will not be defined by oral appliances alone[rw5] . It will be defined by dentists who choose to practice deliberately, collaboratively, and diagnostically grounded, using the structure of their practices to deliver the continuity that sleep medicine has long needed.

For your ease of access, please find the evidence and resource appendix below.

1. Aserinsky E, Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science. 1953;118(3062):273–274. doi:10.1126/science.118.3062.273
2. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. US Department of Health, Education, and Welfare; 1968.
3. Carskadon MA, Dement WC. Normal human sleep: an overview. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 6th ed. Elsevier; 2017:15–24.

4. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med. 1976;27:465–484. doi:10.1146/annurev.me.27.020176.002341

5. Guilleminault C, Eldridge FL, Simmons FB, Dement WC. Sleep apnea in eight children. Pediatrics.1976;58(1):23–30.

6. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–1235. doi:10.1056/NEJM199304293281704

7. American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events.Current Version. AASM; Darien, IL.

8. Iber C, Ancoli-Israel S, Chesson AL Jr, Quan SF. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. 1st ed. AASM; 2007.

9. Berry RB, Brooks R, Gamaldo CE, et al. The AASM scoring manual updates for 2017. J Clin Sleep Med.2017;13(5):665–666. doi:10.5664/jcsm.6576

10. Collop NA, Anderson WM, Boehlecke B, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea. J Clin Sleep Med. 2007;3(7):737–747.

11. Rosen IM, Kirsch DB, Chervin RD, et al. Clinical use of a home sleep apnea test: An American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2017;13(10):1205–1207. doi:10.5664/jcsm.6774

12. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea. J Clin Sleep Med. 2017;13(3):479–504. doi:10.5664/jcsm.6506

13. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136–143. doi:10.1513/pats.200709-155MG

14. Malhotra A, Owens RL. What is central sleep apnea? Respir Care. 2010;55(9):1168–1178.

15. Azarbarzin A, Sands SA, Stone KL, et al. The hypoxic burden of sleep apnea predicts cardiovascular disease–related mortality. Am J Respir Crit Care Med. 2019;199(7):903–910. doi:10.1164/rccm.201806-1141OC

16. Jubran A. Pulse oximetry. Crit Care. 2015;19:272. doi:10.1186/s13054-015-0984-8

17. Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial bias in pulse oximetry measurement. N Engl J Med. 2020;383(25):2477–2478. doi:10.1056/NEJMc2029240

18. Fawzy A, Wu TD, Wang K, Robinson ML, Farha J, Bradke A. Racial and ethnic discrepancy in pulse oximetry and delayed identification of treatment eligibility. JAMA Intern Med. 2022;182(7):730–738. doi:10.1001/jamainternmed.2022.1906

19. Institute of Medicine. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. National Academies Press; 2006.

20. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy. Proc Am Thorac Soc.2008;5(2):173–178. doi:10.1513/pats.200708-119MG

21. Ramar K, Dort LC, Katz SG, et al. Clinical practice guideline for the treatment of obstructive sleep apnea with oral appliance therapy. J Clin Sleep Med. 2015;11(7):773–827. doi:10.5664/jcsm.4858

22. American Academy of Dental Sleep Medicine. Dental Sleep Medicine Standards for Screening, Treatment, and Follow-Up. AADSM; Chicago, IL.

23. Shepard JW Jr. Fifty years of sleep medicine: progress and promise. Chest. 2005;127(1):1–3. doi:10.1378/chest.127.1.1

24. Malhotra RK, Heffron TM, Rosen IM, Quan SF, Kushida CA, Epstein LJ. Sleep and dreams: how the American Academy of Sleep Medicine and its members have shaped the future of the sleep field for 50 years. J Clin Sleep Med. 2025;21(6):1093-1102. doi:10.5664/jcsm.11660